Posted inGenetics
Artiva Axes 94% of Workforce, Weighs Strategic Alternatives After Two Patients in Phase IIa Trial Die
Artiva Biotherpeutics’ corporate headquarters and NK cell therapy research and GMP manufacturing facility in San Diego. Artiva said it will…








